Prognostic Value of Peroxiredoxin-1 Expression in Patients with Solid Tumors: a Meta-Analysis of Cohort Study.

Lianghe JiaoJing WeiJun YeChuanmeng Zhang

Published in: Disease markers (2021)

PRDX1 overexpression is associated with poor outcomes of cancers and may serve as a prognostic biomarker for malignant patients. Hence, PRDX1 could be a new target for antitumor therapy.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
poor prognosis
peritoneal dialysis
prognostic factors
transcription factor
adipose tissue
stem cells
young adults
bone marrow
mesenchymal stem cells
cell therapy